Development of animal models for emerging infectious diseases by breaking the barrier of species susceptibility to human pathogens

被引:4
|
作者
Rong, Na [1 ,2 ]
Liu, Jiangning [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing Key Lab Anim Models Emerging & Remerging, NHC Key Lab Human Dis Comparat Med, Beijing, Peoples R China
[2] Comparat Med Ctr, Peking Union Med Coll, Beijing, Peoples R China
关键词
Emerging infectious diseases; animal model; susceptible animal; human pathogen; susceptibility spectrum; FUNCTIONAL RECEPTOR; COLLABORATIVE CROSS; HOST SUSCEPTIBILITY; CUTTING EDGE; MICE; SARS-COV-2; STAT1; VIRUS; TLR2-DEFICIENT; INTERFERONS;
D O I
10.1080/22221751.2023.2178242
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Outbreaks of emerging infectious diseases pose a serious threat to public health security, human health and economic development. After an outbreak, an animal model for an emerging infectious disease is urgently needed for studying the etiology, host immune mechanisms and pathology of the disease, evaluating the efficiency of vaccines or drugs against infection, and minimizing the time available for animal model development, which is usually hindered by the nonsusceptibility of common laboratory animals to human pathogens. Thus, we summarize the technologies and methods that induce animal susceptibility to human pathogens, which include viral receptor humanization, pathogen-targeted tissue humanization, immunodeficiency induction and screening for naturally susceptible animal species. Furthermore, the advantages and deficiencies of animal models developed using each method were analyzed, and these will guide the selection of susceptible animals and potentially reduce the time needed to develop animal models during epidemics.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Emerging infectious diseases and pathogens
    Chou, T
    [J]. NURSING CLINICS OF NORTH AMERICA, 1999, 34 (02) : 427 - +
  • [2] Breaking the species barrier: use of SCID mouse-human chimeras for the study of human infectious diseases
    Davis, PH
    Stanley, SL
    [J]. CELLULAR MICROBIOLOGY, 2003, 5 (12) : 849 - 860
  • [3] Emerging bacterial infectious diseases/pathogens vectored by human lice
    Deng, Yuan-Ping
    Fu, Yi-Tian
    Yao, Chaoqun
    Shao, Renfu
    Zhang, Xue-Ling
    Duan, De-Yong
    Liu, Guo-Hua
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2023, 55
  • [4] Emerging Pathogens and Knowledge in Infectious Diseases
    Greenfield, Ronald A.
    Bronze, Michael S.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 340 (03): : 177 - 180
  • [5] Animal Models Facilitate Rapid Responses to Emerging Infectious Diseases
    Kurilla, Michael
    [J]. ILAR JOURNAL, 2011, 52 : 501 - 506
  • [6] The emerging role of infectious pathogens in neurodegenerative diseases
    Langford, D
    Masliah, E
    [J]. EXPERIMENTAL NEUROLOGY, 2003, 184 (02) : 553 - 555
  • [7] Key pathogens and emerging therapies in infectious diseases
    Miller, Paul F.
    Mueller, John P.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (05) : 535 - 536
  • [8] Emerging zoonotic infectious diseases: a folly of human development
    Tenorio, J. C. B.
    [J]. JOURNAL OF LIVESTOCK SCIENCE, 2022, 13 : 76 - 79
  • [9] Emerging infectious diseases: opportunities at the human-animal-environment interface
    Dixon, Matthew A.
    Dar, Osman A.
    Heymann, David L.
    [J]. VETERINARY RECORD, 2014, 174 (22) : 546 - 551
  • [10] The Impact of Fusarium Mycotoxins on Human and Animal Host Susceptibility to Infectious Diseases
    Antonissen, Gunther
    Martel, An
    Pasmans, Frank
    Ducatelle, Richard
    Verbrugghe, Elin
    Vandenbroucke, Virginie
    Li, Shaoji
    Haesebrouck, Freddy
    Van Immerseel, Filip
    Croubels, Siska
    [J]. TOXINS, 2014, 6 (02) : 430 - 452